Delivery Order SPE2DB20D1109-SPE2DB25FN84A
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The order is for 4,565,338,781 units of the pharmaceutical product RYANODEX 250 MG VIALS, with a ceiling value of $2,979.28. The contract is a firm fixed-price delivery order with an ultimate completion date of August 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,421.76 firm-fixed-price contract is for the supply of RYANODEX 250 MG VIALS, a medical product, to support military healthcare programs. The contract has an ultimate completion date of March 7, 2025 and was awarded on February 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded to AmerisourceBergen Drug Corp Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the U.S. Department of Defense. The contract is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract has a firm-fixed price ceiling value of $22,344.60 and a completion date of September 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product, with a ceiling value of $16,054.40 and a completion date of July 30, 2025. The contract is a firm fixed price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, valued at $5,958.56, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,564,667,602 units of the pharmaceutical product RYANODEX 250MG VIAL 1S, with a performance period ending on June 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,448.96, is for the supply of RYANODEX 250MG VIAL 1S, a medical product. The contract is a firm fixed-price delivery order with a performance period ending on May 14, 2025. It is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RYANODEX 250 MG VIALS. The contract has a potential value of $1,489.64 and a completion date of March 14, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,210.88 and is a Firm Fixed Price Delivery Order for RYANODEX 250 MG VIALS. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division (Vendor ID: TGxsdkVQRGhOYUpNR001SFhYREdNdz09) is for the supply of RYANODEX 250 MG VIALS (Contract ID: SPE2DB22D3011|SPE2DB24FQ1RR) to the Defense Logistics Agency (DLA), with a ceiling value of $7,448.20. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is June 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant...
- This is a contract award to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distribution company, to provide RYANODEX 250 MG VIALS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,448.20 and is a Firm Fixed Price Delivery Order, with a completion date of July 9, 2024. The contract is not set aside and was awarded on June 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FN84ADelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,605.44, is for the delivery of 4,567,850,322 units of the medication RYANODEX 250 MG VIALS. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 4/7/25 |